Paul Reider
Chief Commercial Officer · Coherus BioSciences, Inc.
Individual
- 2024
- Dec 17, 2024
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Paul Reider's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- EcoR1 Capital, LLC - $40.00M in AKTS purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $40.00M in BCAX purchases and sales in the last 12 months
- Sanj K. Patel - $39.43M in KNSA purchases and sales in the last 12 months
- Hellman & Friedman Capital Partners X (Parallel), L.P. - $2.65B in MDLN purchases and sales in the last 12 months
- BX Mozart ML-2 Holdco L.P. - $2.35B in MDLN purchases and sales in the last 12 months
- BCP 8 Holdings Mozart Manager L.L.C. - $2.35B in MDLN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Paul Reider?
Paul Reider is a corporate insider, tracked as Chief Commercial Officer of Coherus BioSciences, Inc. (CHRS). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Paul Reider last file a Form 4?
The only primary Form 4 on record is dated 17 December 2024.
